Socma Pushes for Greater U.S. Oversight of Overseas API Production
CW Editorial Staff
Socma has asked the U.S. FDA to beef up inspections of foreign facilities manufacturing active pharmaceutical ingredients (APIs). Socma and the Bulk Pharmaceuticals Task Force submitted comments on an FDA advisory panel’s recent report “FDA...
This information is only available to Chemical Week 24/7 members and subscribers.
Not a Chemical Week
24/7 member yet? Here's why you
should be: Searchable online archive
access of the last 2 years
of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers